|
Senseonics Holdings, Inc. Schedules Second Quarter 2022 Earnings Release and Conference Call for August 9, 2022, at 4:30 p.m. Eastern Time
07/26/2022
|
|
|
Senseonics Announces Equity Grants To Employees Under Inducement Plan
07/05/2022
|
|
|
Senseonics Announces CE Mark Approval of the Eversense E3 Continuous Glucose Monitoring System
06/16/2022
|
|
|
Senseonics to Participate in the Jefferies Healthcare Conference
05/26/2022
|
|
|
Senseonics to Participate in the H.C. Wainwright Global Investment Conference
05/16/2022
|
|
|
Senseonics Holdings, Inc. Reports First Quarter 2022 Financial Results
05/10/2022
|
|
|
Senseonics Holdings, Inc. Schedules First Quarter 2022 Earnings Release and Conference Call for May 10, 2022, at 4:30 p.m. Eastern Time
04/26/2022
|
|
|
Senseonics Announces the First Patient Implant of the Eversense E3 CGM System in the U.S.
04/06/2022
|
|
|
Senseonics Announces Equity Grants to Employees Under Inducement Plan
04/01/2022
|
|
|
Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results
03/01/2022
|
|